ACE Team

Dan Renick brings more than 30 years of healthcare knowledge and executive experience to his role as CEO of Petauri. Dan also serves as a member of the Petauri Board of Directors. A proven leader with extensive private equity experience, Dan provides visionary leadership to life sciences innovators with highly effective, strategic, and pragmatic solutions to commercialization challenges. Previously, Dan was a founding executive and President of Precision Value & Health, following their acquisition of Hobart Group Holdings, in 2013. Under Dan’s leadership, Precision Value & Health experienced outsized organic growth, completed numerous strategic acquisitions, and received multiple industry awards.

He is also cofounder of Quantuvis and a current member of its Board of Directors. Quantuvis is the market leader in comprehensive software solutions for life sciences companies and payers, partnering with them to create value and innovation while addressing affordability.

A highly regarded market access and pharmaceutical services leader, Dan has demonstrated an exceptional talent for identifying and addressing market access obstacles, crucial for ensuring optimal patient access to healthcare innovations and medical advances. With over 20 years of vast and diverse market access experience, Dan has honed his expertise through a variety of leadership roles at various payer and pharmaceutical services organizations.

At Humana, Dan served on the company’s Formulary Strategy Team and P&T Committee, with sole responsibility for negotiation, implementation, and management of all Medicare rebate agreements. Dan made the transition to pharmaceutical service providers at The Hobart Group, in 2012. Most recently, Dan served as SVP, Managing Director at Precision Value & Health, where he navigated the complexities of value and access, on behalf of hundreds of clients, contributing to the company’s continued growth and success.

Dan received his PharmD from the University of Pittsburgh, followed by a postdoctoral residency in managed care pharmacy, a fellowship in pharmacoeconomics and health outcomes research, and a graduate certificate in epidemiology from the University of Louisville School of Public Health & Information Sciences.